The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I agree , especially given two factors
1. Sareum and the aim bio sector has a tendancy for share prices to spike upwards significantly on favourable news
2. we can see that only a couple of trades moves the price up or down . Wait till there is news ie a milestone is confirmed or a licence deal this share price will spike significantly, it has done before and i am sure it will again
I am sure Tim and John are working with a clear focuson the end game
My only concern is whether the incentives are correctly balanced. The longer it takes the more significant salaries are paid toTim and John and BOD, and hopefully a better deal licence /t/o ., especially as a lot of their options are underwater at present.
Risk a competitor beats Sareum to the end game or fail in clinical trial .I would like real incentives to be implemented to in essence to speed matters along and reduce the risk by agreeing a license, t/o or even a JV . Interested to see other investors views are
Good luck all LT H
D.
You can't change market sentiment it is what it is. But we have to deal with facts and the they are positively stacked towards Sar. As everyone knows a deal could be announced out of the blue as has been done before in many a Pharma and Sar to date have not been leaky- However, when the inevitable deal(s) is/are announced for Tyk2 and Chk1 (if Sierra decide to on licence) then we all are fully aware how AIM prices move we have seen it with many other Pharma including Sar.
Actually could be the complete opposite (says the optimist in me) as those b'tard MM have a tendancy to mark stock down/keep them down in order to build positions quielty often over a long period of time ...
Correct and considering that share prices now reflect all information available including projections I would say that the market is pretty un confident that a license deal is close
Because there is zero cash flow now or being projected by anything concrete.
Why are we at a 3 year low then? Has anyone got a decent opinion?
To take apart the val comparison.
1. It is on licensed with milestones. Val is not
2. CRT cruk have been actively involved in preclinical development. Not at val
3. Are completing p2 trials with hundreds of people in multiple uk and European centres. With world leading authorities supervising. Val has a few people in the Ukraine.
Quite quite different and am sorry for your loss on val
2
We must be in the high 9 hundreds if this is to be a death of a thousand cuts.
Yep
History has told us that the only way to make a small fortune out of investing in AIM is to start with a large one and work down.
Been invested here longer than most and have built up a decent holding . Lucky to have traded a few at the right time over the years to leave me with a very decent average .
As long as the science remains top notch I will stay in and take my chance.
An SP here of a measly 3p would not only wipe out all the losses I have had with a very long list of AIM disasters but would also leave me with a decent few quid over the top.
Like a lot of others I think I will stick with my holding here and see how things pan out .
About time one share on AIM bucked the normal downward trend .
With cautious optimism , I believe that SAR has as good a chance as any of being the one.
I think you just confirmed frank s thought . We are in a really good position but we could go bust! No frigging commercial deals not even close to and the one we have licensed has not paid milestone and have now given up 10% of company because it cannot pay milestone or does not back itself enough.
Frank, there is a despairing difference between Sar and Val- for 1 we have licenced a compound, although at the moment it is temporarily not being funded fully by Sierra it is still being used in hospitals across the UK, Spain and US as per the prev. RNS's. Additionally we are in exceptionally hot territory with Tyk2 and we have 2 indications Cancer and Auto-immune and have shown our compound works in auto-immune albeit in mouse studies with Pfizer against their own marketed Tofa and the SRI and US Army in Lupus. So we are unlikely to go Val's way- that said if they pull all projects or find that the compounds aren't as good as they have been showing pre-clinical then we could end up bust, it is AIM and Pharma after all.
Utah you are 100% , we are no closer , all the bar room scientist are feeding this rubbish,
Sar will go the same as Val
12 years same old same old, gravy train for Bod.
At least they will get to xmas party
What happend to the EGM........